semaglutide glaucoma Anterior ischemic optic neuropathy in patients treated with semaglutide: report of four cases with a possible association | BMC Ophthalmology A new study suggests patients

This FDA-approved weight loss variant of semaglutide is administered via a weekly injection and is geared towards adults with a BMI of 30 or higher, or 27 and higher with at least one weight-related condition

If you find the 45 unit mark uncomfortably small to read, the honest options are (a) use a finer-gradation syringe, or (b) follow a protocol built around the 50 mg vial, whose larger draw is more forgiving not to freehand a bigger volume from the 10 mg vial, which would silently overdose relative to the documented figure

The abdomen is the most commonly used and typically most comfortable injection site

Medical nutrition therapy interventions provided by dietitians for adult overweight and obesity management: an academy of nutrition and dietetics Evidence-Based practice guideline